Vraylar 3 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM40N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,683
Award facts
- Contract value 100% obligated
- $69,682.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,682.67 delivery order to AmerisourceBergen Drug Corp for the supply of Vraylar 3 mg capsules (30-count units) under a firm fixed-price contract. This non-set-aside award, issued on January 14, 2026, with an ultimate completion date of January 15, 2026, represents a task order executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The prime vendor agreement, valued at $999,999,999.00 through December 2026, serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., which holds the master IDC with DLA.
Vraylar is a neurological medication used in military and veteran healthcare systems as part of DLA's broad pharmaceutical supply chain supporting the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. The delivery order exemplifies the routine pharmaceutical procurement activities conducted through DLA's pharmaceutical prime vendor program, which enables efficient and flexible sourcing of essential medications across multiple therapeutic domains. AmerisourceBergen's consistent receipt of competitive delivery orders under this vehicle demonstrates its capability to meet federal medical supply requirements and maintain critical inventory for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM40N?
SPE2DR26FM40N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FM40N worth?
The government has obligated $69,683 on SPE2DR26FM40N.
Is contract SPE2DR26FM40N an order under another contract?
Yes. SPE2DR26FM40N is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM40N competed?
The extent of competition for SPE2DR26FM40N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award